首页> 外文期刊>Technology in cancer research & treatment. >Hippocampus-Sparing Whole-Brain Radiotherapy and Simultaneous Integrated Boost for Multiple Brain Metastases From Lung Adenocarcinoma: Early Response and Dosimetric Evaluation
【24h】

Hippocampus-Sparing Whole-Brain Radiotherapy and Simultaneous Integrated Boost for Multiple Brain Metastases From Lung Adenocarcinoma: Early Response and Dosimetric Evaluation

机译:保留海马全脑放疗和同时整合Boost治疗多发性肺腺癌脑转移:早期反应和剂量学评估

获取原文
获取原文并翻译 | 示例
           

摘要

In this study, the volume response and treatment outcome after hippocampus-sparing whole-brain radiotherapy (HS-WBRT) with simultaneous integrated boost (SIB) using tomotherapy were evaluated. Patients with primary lung adenocarcinoma and multiple brain metastases who had a Karnofsky performance status >= 70 and exhibited well-controlled extracranial disease were treated. The prescribed dose was administered in 10 to 14 fractions as 25 to 28 Gy to whole-brain parenchyma, as 40 to 48 Gy to the gross metastatic lesion, and as 30 to 42 Gy to a 5-mm margin to the metastatic lesion. Double-dose gadolinium contrast-enhanced magnetic resonance imaging at 1-mm slice thickness was performed before treatment and at 1, 4, and 7 months post-treatment. The tumor volume reduction ratio was calculated for each follow-up. Between July 2011 and September 2012, 11 patients with 70 lesions were included in this analysis. The median number of lesions per patient was 4 (range, 2-15). The median initial tumor volume was 0.235 cm(3) (range, 0.020-10.140 cm(3)). The treatment plans were evaluated regarding conformation number (CN), target coverage (TC), and homogeneity index (HI). The median follow-up duration was 14 months (range, 3-25 months) and the 1-year intracranial control rate was 67%. The tumor volume reduction was most prominent during the first month with a median reduction rate of 0.717 (range, -0.190 to 1.000). Complete remission was seen in 22 (33%) lesions, and 45 (64%) lesions showed more than 65% reduction in tumor volume. The CN, TC, and HI values were comparable to that of previous studies, and the mean hippocampal dose was 13.65 Gy. No treatment breaks or >= G3 acute toxicities were observed during or after treatment. The HS-WBRT with SIB in patients with multiple brain metastases was effective and feasible for volume reduction and showed excellent intracranial control.
机译:在这项研究中,评估了使用tomotherapy进行海马保留全脑放疗(HS-WBRT)并同时进行综合加强(SIB)治疗后的体积反应和治疗效果。治疗Karnofsky行为状态> = 70并表现出良好控制的颅外疾病的原发性肺腺癌和多发性脑转移患者。规定剂量以10到14份的比例给予全脑实质,以25到28 Gy给予总转移灶,以40到48 Gy给予转移灶,转移灶为5 mm。在治疗前和治疗后1、4和7个月以1毫米厚的双剂量ado造影增强磁共振成像。计算每次随访的肿瘤体积减少率。在2011年7月至2012年9月之间,该分析纳入了11个有70个病变的患者。每位患者的病变平均数为4(范围2-15)。中位初始肿瘤体积为0.235 cm(3)(范围0.020-10.140 cm(3))。对治疗计划进行了构象数(CN),目标覆盖率(TC)和均一性指数(HI)评估。中位随访时间为14个月(范围3-25个月),1年颅内控制率为67%。在第一个月中,肿瘤体积减少最为明显,中位减少率为0.717(范围-0.190至1.000)。在22个(33%)病变中观察到完全缓解,而45(64%)个病变显示肿瘤体积减少了65%以上。 CN,TC和HI值与以前的研究相当,平均海马剂量为13.65 Gy。在治疗期间或之后未观察到治疗中断或> = G3急性毒性。具有多发性脑转移的SIB的HS-WBRT对于减少体积是有效且可行的,并表现出出色的颅内控制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号